Interventional Cardiology Department, Minneapolis Heart institute, Minneapolis, Minnesota, USA.
Clin Cardiol. 2020 Dec;43(12):1368-1375. doi: 10.1002/clc.23499. Epub 2020 Nov 11.
A linear increase in the number of valvular heart disease is expected due to the aging population, yet most patients with severe valvular heart disease remain undiagnosed.
POCUS can serve as a screening tool for valvular heart disease.
We reviewed the literature to assess the strengths and limitations of POCUS in screening and diagnosing valvular heart disease.
POCUS is an accurate, affordable, accessible, and comprehensive tool. It has a fast learning curve and can prevent unnecessary and more expensive imaging. Challenges include training availability, lack of simplified screening protocols, and reimbursement. Large scale valvular screening data utilizing POCUS is not available.
POCUS can serve as a screening tool and guide the management of patients with valvular heart disease. More data is needed about its efficacy and cost-effectiveness in the screening of patients with valvular heart disease.
由于人口老龄化，预计瓣膜性心脏病的数量将呈线性增长，但大多数患有严重瓣膜性心脏病的患者仍未得到诊断。
POCUS 可作为瓣膜性心脏病的筛查工具。
我们回顾了文献，以评估 POCUS 在筛查和诊断瓣膜性心脏病方面的优势和局限性。
POCUS 是一种准确、经济实惠、易于获得且全面的工具。它具有快速的学习曲线，可以避免不必要的、更昂贵的影像学检查。挑战包括培训的可及性、缺乏简化的筛查方案以及报销问题。目前还没有利用 POCUS 进行大规模瓣膜筛查的数据。
POCUS 可作为一种筛查工具，指导瓣膜性心脏病患者的管理。需要更多关于 POCUS 在瓣膜性心脏病患者筛查中的疗效和成本效益的数据。
